Page last updated: 2024-12-08

dibenzheptropine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

dibenzheptropine: minor descriptor (65-85); on-line & Index Medicus search TROPANES (66-85); RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

deptropine : An azabicycloalkane that is the 10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl ether of tropine. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID203911
CHEMBL ID1946186
CHEMBL ID1622878
CHEBI ID50189
CHEBI ID94419
SCHEMBL ID28710
MeSH IDM0263055

Synonyms (44)

Synonym
deptropine
604-51-3
deptropinum
(3-endo)-3-(10,11-dihydro-5h-dibenzo[a,d]cyclohepten-5-yloxy)-8-methyl-8-azabicyclo[3.2.1]octane
dibenzheptropine
deptropina
endo-3-[(10,11-dihydro-5h-dibenzo[a,d]cyclohepten-5-yl)oxy]-1alphah,5alphah-tropane
endo-3-[(10,11-dihydro-5h-dibenzo[a,d]cyclohepten-5-yl)oxy]-8-methyl-8-azabicyclo[3.2.1]octane
CHEBI:50189 ,
ay31301gkg ,
deptropine [inn:ban]
deptropina [inn-spanish]
8-azabicyclo(3.2.1)octane, 3-((10,11-dihydro-5h-dibenzo(a,d)cyclohepten-5-yl)oxy)-8-methyl-, endo-
tropane, 3alpha-((10,11-dihydro-5h-dibenzo(a,d)cyclohepen-5-yl)oxy)-
1alphah,5alphah-tropane, 3alpha-((10,11-dihydro-5h-dibenzo(a,d)cyclohepten-5-yl)oxy)-
deptropinum [inn-latin]
8-azabicyclo(3.2.1)octane, 3-((10,11-dihydro-5h-dibenzo(a,d)cyclohepten-5-yl)oxy)-8-methyl-, (3-endo)-
3-(10,11-dihydro-5h-dibenzo(a,d)cyclohepten-5-yloxy)tropane
einecs 210-069-0
unii-ay31301gkg
bdbm50419751
CHEMBL1946186
3.alpha.-((10,11-dihydro-5h-dibenzo(a,d)cyclohepten-5-yl)oxy)tropane
deptropine [who-dd]
deptropine [inn]
1.alpha.h,5.alpha.h-tropane, 3.alpha.-((10,11-dihydro-5h-dibenzo(a,d)cyclohepten-5-yl)oxy)-
3.alpha.-((10,11-dihydro-5h-dibenzo(a,d)cyclohepten-5-yl)oxy)-1.alpha.h,5.alpha.h-tropane
deptropine [mi]
endo-3-((10,11-dihydro-5h-dibenzo(a,d)cyclohepten-5-yl)oxy)-8-methyl-8-azabicyclo(3.2.1)octane
tropane, 3.alpha.-((10,11-dihydro-5h-dibenzo(a,d)cyclohepten-5-yl)oxy)-
SCHEMBL28710
citric acid;(1s,5r)-3-(6,11-dihydro-5h-dibenzo[1,2-a:1'',2''-e]cyclohepten-11-yloxy)-8-methyl-8-azabicyclo[3.2.1]octane
(1s,5r)-3-(6,11-dihydro-5h-dibenzo[1,2-a:1'',2''-e][7]annulen-11-yloxy)-8-methyl-8-azabicyclo[3.2.1]octane;2-hydroxypropane-1,2,3-tricarboxylic acid
bdbm79210
(1s,5r)-3-(6,11-dihydro-5h-dibenzo[1,2-a:1'',2''-e][7]annulen-11-yloxy)-8-methyl-8-azabicyclo[3.2.1]octane;2-oxidanylpropane-1,2,3-tricarboxylic acid
cid_6604492
DTXSID5048556
CHEMBL1622878
CHEBI:94419
Q5260984
Q27166277
(1s,5r)-3-(6,11-dihydro-5h-dibenzo[1,2-a:1',2'-e][7]annulen-11-yloxy)-8-methyl-8-azabicyclo[3.2.1]octane
DB13466
(1r,5s)-8-methyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,11,13-hexaenyloxy)-8-azabicyclo[3.2.1]octane
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
organic tricyclic compound
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (2)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Acetylcholine-binding proteinLymnaea stagnalis (great pond snail)Ki1.19670.00011.881128.0000AID415528; AID644038
Soluble acetylcholine receptorAplysia californica (California sea hare)Ki6.30960.00101.22766.3096AID644039
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (15)

Assay IDTitleYearJournalArticle
AID644038Displacement of [3H]epibatidine from Lymnaea stagnalis acetylcholine binding protein expressed using baculoviral system after 1.5 hrs by scintillation counting2012Bioorganic & medicinal chemistry letters, Feb-01, Volume: 22, Issue:3
Structure-based design, synthesis and structure-activity relationships of dibenzosuberyl- and benzoate-substituted tropines as ligands for acetylcholine-binding protein.
AID1480299Selectivity index, ratio of cytotoxic activity for HEK293 cells to IC50 for Ebolavirus glycoprotein/matrix protein VP40 entry in human HeLa cells2018Journal of medicinal chemistry, 04-26, Volume: 61, Issue:8
Computer-Aided Discovery and Characterization of Novel Ebola Virus Inhibitors.
AID644040Displacement of [3H]MLA from nAChR alpha7 receptor in human SH-SY5Y cells by scintillation counting2012Bioorganic & medicinal chemistry letters, Feb-01, Volume: 22, Issue:3
Structure-based design, synthesis and structure-activity relationships of dibenzosuberyl- and benzoate-substituted tropines as ligands for acetylcholine-binding protein.
AID415528Displacement of [125I]alpha-bungarotoxin from Lymnaea stagnalis His-tagged AchBP2009Journal of medicinal chemistry, Apr-23, Volume: 52, Issue:8
Use of acetylcholine binding protein in the search for novel alpha7 nicotinic receptor ligands. In silico docking, pharmacological screening, and X-ray analysis.
AID458778Displacement of [125I]CCL5 from HCMV US28 receptor at 10 uM2010Bioorganic & medicinal chemistry, Jan-15, Volume: 18, Issue:2
Identification of novel allosteric nonpeptidergic inhibitors of the human cytomegalovirus-encoded chemokine receptor US28.
AID1480298Inhibition of Ebolavirus glycoprotein/matrix protein VP40 entry in human HeLa cells after 4.5 hrs beta-lactamase reporter assay2018Journal of medicinal chemistry, 04-26, Volume: 61, Issue:8
Computer-Aided Discovery and Characterization of Novel Ebola Virus Inhibitors.
AID644041Displacement of [3H]epibatidine from human nAChR alpha4beta2 receptor expressed in human HEK293T cells by scintillation counting2012Bioorganic & medicinal chemistry letters, Feb-01, Volume: 22, Issue:3
Structure-based design, synthesis and structure-activity relationships of dibenzosuberyl- and benzoate-substituted tropines as ligands for acetylcholine-binding protein.
AID1480305Inhibition of NPC1 in human fibroblasts assessed as increase in cholesterol accumulation after 24 hrs by filipin staining-based assay2018Journal of medicinal chemistry, 04-26, Volume: 61, Issue:8
Computer-Aided Discovery and Characterization of Novel Ebola Virus Inhibitors.
AID1480300Selectivity index, ratio of cytotoxic activity for human HeLa cells to IC50 for Ebolavirus glycoprotein/matrix protein VP40 entry in human HeLa cells2018Journal of medicinal chemistry, 04-26, Volume: 61, Issue:8
Computer-Aided Discovery and Characterization of Novel Ebola Virus Inhibitors.
AID458779Activity at HCMV US28 receptor assessed as receptor-mediated inositol phosphate response at 10 uM2010Bioorganic & medicinal chemistry, Jan-15, Volume: 18, Issue:2
Identification of novel allosteric nonpeptidergic inhibitors of the human cytomegalovirus-encoded chemokine receptor US28.
AID1480303Inhibition of recombinant cathepsin L (unknown origin) at 10 uM using Ac-FR-AFC as substrate preincubated for 29 mins followed by substrate addition by fluorescence-based assay2018Journal of medicinal chemistry, 04-26, Volume: 61, Issue:8
Computer-Aided Discovery and Characterization of Novel Ebola Virus Inhibitors.
AID644039Displacement of [3H]epibatidine from Aplysia californica acetylcholine binding protein expressed using baculoviral system after 1.5 hrs by scintillation counting2012Bioorganic & medicinal chemistry letters, Feb-01, Volume: 22, Issue:3
Structure-based design, synthesis and structure-activity relationships of dibenzosuberyl- and benzoate-substituted tropines as ligands for acetylcholine-binding protein.
AID1480302Binding affinity to Ebolavirus glycoprotein/matrix protein VP40 at 50 uM incubated for 10 mins by thermal shift assay2018Journal of medicinal chemistry, 04-26, Volume: 61, Issue:8
Computer-Aided Discovery and Characterization of Novel Ebola Virus Inhibitors.
AID1480306Increase in lysosome size in human fibroblasts after 24 hrs by LysoTracker Red DND-99-based assay2018Journal of medicinal chemistry, 04-26, Volume: 61, Issue:8
Computer-Aided Discovery and Characterization of Novel Ebola Virus Inhibitors.
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (31)

TimeframeStudies, This Drug (%)All Drugs %
pre-199011 (35.48)18.7374
1990's12 (38.71)18.2507
2000's2 (6.45)29.6817
2010's6 (19.35)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.00

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.00 (24.57)
Research Supply Index3.50 (2.92)
Research Growth Index4.49 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.00)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (3.13%)6.00%
Case Studies1 (3.13%)4.05%
Observational0 (0.00%)0.25%
Other30 (93.75%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]